The next pandemic will not wait: universal vaccines, pandemic preparedness, and the integrity of vaccine policy

“What the field needs is better translation of complex immunogenicity and benefit‑risk data into terms that are meaningful to clinicians, public health practitioners, and the public.”

Ashling Cannon, Commissioning Editor, Vaccine Insights, speaks with Michael Osterholm, Director, Center for Infectious Disease Research and Policy, University of Minnesota, about the pathogen characteristics that define a worst‑case pandemic scenario, the current pipeline of broadly protective influenza vaccines, the role of mRNA technology in pandemic preparedness, and and the challenges facing public health infrastructure in the United States.

Please enter your email to access content Read now